[VRTX] YoY Quarter Result on 30-Jun-2016 [#Q2]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
01-Aug-2016
Financial Year
2016
Quarter
30-Jun-2016 [#Q2]
Profit Trend
QoQ- -54.99%
YoY- 65.83%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Quarter Result
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
Revenue 941,293 752,157 544,135 431,608 166,076 138,421 310,750 20.27%
PBT 327,138 216,591 35,506 -18,021 -190,861 -158,689 -63,511 -
Tax 59,711 10,341 4,337 18,130 30,131 693 -1,799 -
NP 267,427 207,360 17,996 -64,525 -188,848 -159,382 -57,165 -
Tax Rate -18.25% -4.77% -12.21% - - - - -
Total Cost 673,866 544,797 526,139 496,133 354,924 297,803 367,915 10.60%
Ratio Analysis
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
NP Margin 28.41 27.57 3.31 -14.95 -113.71 -115.14 -18.40 -
Per Share
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
EPS 1.04 0.82 0.07 -0.26 -0.78 -0.68 -0.26 -
EPS Diluted 1.03 0.80 0.07 -0.26 -0.78 -0.68 -0.26 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.